Elivate: creating change through liver education is an educational program for healthcare professionals to raise awareness, promote screening, and enhance management of MASH for US patients.
Content current as of January 2026.
Module 1
MASH
overview
This module provides an overview of MASH, including associated burden and comorbidities and guideline recommendations for diagnosis and management.
Estimated learning time: 15 min
Watch an introduction from Dr. Chaney
Introductory video
1:10 min
Download the full slide deck for offline use
MASH overview PowerPoint
16 slides
Watch a summary from Dr. Chaney
Module 2
Patient
identification
and risk factors
This module discusses the comorbidities associated with MASH and the burden patients may experience.
Estimated learning time: 15 min
Watch an introduction from Dr. Mena
Introductory video
1:14 min
Download the full slide deck for offline use
Preview a topic from the slide deck
Watch a summary from Dr. Mena
Closing video
1:10 min
Module 3
Screening
and diagnostics
This module outlines diagnostic recommendations and describes the various clinical screening tools recommended by guidelines.
Estimated learning time: 15 min
Watch an introduction from Dr. Mena
Introductory video
1:10 min
Watch an animation explaining diagnostic screening recommendations
The use of non-invasive tests (NITs) to screen patients at risk of MASH video
3:18 min
Download the full slide deck for offline use
Preview a topic from the slide deck
Watch a summary from Dr. Mena
Closing video
00:53 min
Module 4
MASH
management
This module summarizes how holistic management supports patient outcomes and details the current approved therapeutic options.
Estimated learning time: 15 min
Watch an introduction from Dr. Chaney
Introductory video
1:12 min
Download the full slide deck for offline use
Preview a topic from the slide deck
Watch a summary from Dr. Chaney
Closing video
1:03 min
The purpose of this site is to provide relevant medical and scientific information about Novo Nordisk products and areas of therapeutic interest. Information about investigational products or investigational uses of approved products neither implies FDA approval for these products or uses, nor establishes the safety or efficacy of these products or uses. There is no guarantee that any investigational product or investigational use will receive FDA approval or become commercially available in the United States. Novo Nordisk does not recommend or suggest use of its products in any manner inconsistent with FDA-approved labeling.
This site is intended for United States healthcare professionals only. The information on this site—including all product information—pertains to residents of the United States only. Any products referenced on this site may have different labelling in different countries.
